Financhill
Back

Pliant Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Pliant Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 12.46 Sell
20-day SMA: 13.68 Sell
50-day SMA: 14.85 Sell
200-day SMA: 16.03 Sell
8-day EMA: 12.54 Sell
20-day EMA: 13.39 Sell
50-day EMA: 14.51 Sell
200-day EMA: 16.57 Sell

Pliant Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.82 Sell
Relative Strength Index (14 RSI): 28.07 Sell
Chaikin Money Flow: 572527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.82 - 14.9) Sell
Bollinger Bands (100): (14.18 - 17.6) Sell

Pliant Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Pliant Therapeutics Stock

Is Pliant Therapeutics Stock a Buy?

PLRX Technical Analysis vs Fundamental Analysis

Sell
19
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?

Pliant Therapeutics Stock Info

Market Cap:
715.64M
Price in USD:
11.88
Share Volume:
607.76K

Pliant Therapeutics 52-Week Range

52-Week High:
28.80
52-Week Low:
11.21
Sell
19
Pliant Therapeutics (PLRX) is a Sell

Pliant Therapeutics Share Price Forecast

Is Pliant Therapeutics Stock a Buy?

  • Pliant Therapeutics share price is 11.88 while PLRX 8-day exponential moving average is 12.54, which is a Sell signal.
  • The stock price of PLRX is 11.88 while Pliant Therapeutics 20-day EMA is 13.39, which makes it a Sell.
  • Pliant Therapeutics 50-day exponential moving average is 14.51 while PLRX share price is 11.88, making it a Sell technically.
  • PLRX stock price is 11.88 and Pliant Therapeutics 200-day simple moving average is 16.57, creating a Sell signal.

Fundamental Analysis of Pliant Therapeutics

Is Pliant Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.25 per share.

Technical Analysis of Pliant Therapeutics

Should I short Pliant Therapeutics stock?

* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.